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1. Introduction 
Acute aluminium phosphide poisoning is an extremely lethal poisoning. Ingestion is usually 
suicidal in intent, uncommonly accidental and rarely homicidal. Unfortunately the absence 
of a specific antidote results in very high mortality and the key to treatment lies in rapid 
decontamination and institution of resuscitative measures.Aluminium phosphide is a solid 
fumigant which has been in extensive use since the 1940s. It has rapidly become one of the 
most commonly used grain fumigants because of its properties which are considered to be 
near ideal; it is toxic to all stages of insects, highly potent, does not affect seed viability, is 
free from toxic residues and leaves little residue on food grains(Hackenberg, 1972). 
They are formulated as compressed discs, tablets or pellets that commonly weigh 3 g and 
contain variable amounts of a single phosphide in combination with other substances such as 
ammonium carbonate. Tablets are dark brown or grayish in colour. It is freely available in the 
markets with the major virtues of being cheap and not leaving toxic residues. The specified 
fatal dose in human is 0.15-0.5 gm. Phosphides are used widely to protect grain held in stores, 
the holds of ships and in wagons transporting it by rail and are admixed with the grain at a 
predetermined rate as it is put into storage. Moisture in the air between the grains mixes with 
phosphide and release phosphine (hydrogen phosphide, phosphorus trihydride, PH3) which 
is the active pesticide. After contact with an acid, phosphine is released even more vigorous. 
Two kinds of acute poisoning with these substances are reported: indirect inhalation of the 
phosphine generated during their approved use or direct ingestion of the salts.  
Pure phosphine is colorless and odorless up to toxic concentrations (200 ppm), a view 
accepted by the International Programme on Chemical Safety and others (Pepelko, et al, 
2004; Chaudhry, 1997; IPCS, 1988; Dumas & Bond, 1974), it has an odor of garlicky or 
decaying fish due to the presence of substituted phosphines and diphosphines .If the former 
view is accepted the smell emanating from phosphide poisoned patients is probably due to 
contaminants in the pesticide formulations and not phosphine itself. It has been suggested 
that these volatile contaminants may be alkylphosphines (Fluck, 1976). For “phosphine” 
liberated from one pesticidal formulation of aluminium phosphide, the odor threshold was 
0.01–0.02 ppm, ten times lower than that derived from the technical salt alone (Fluck, 
1976).The usefulness of phosphide pesticides is now threatened by the development of 
resistance to them. 
2. Methods 
To complete this review, the terms aluminum and aluminum phosphide and phosphine 
were searched using the TUMS (Tehran University of Medical Science) digital library, 
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Medline, pubmed and Google Scholar databases. All applicable articles in English were 
attained. Many isolated case reports and small case series do not appear in the citation list. 
The ability to highlight important aspects is the only criterion for inclusion in this review. 
The criteria used in the current review include below criteria: Articles were selected based 
on the impact of lifestyle, stress, and/or environmental factor/s predisposing aluminium 
phosphide poisoning exposure. Criteria for selection of the literature used included yes-no 
responses to the appropriateness of methodology; adequacy of subject numbers; specificity 
of sex and/or age of subjects, and statistically significant response rates to survey 
questionnaires. The time frame used was principally 1990-2011 inclusive, although articles 
of extreme importance from earlier decades were used where appropriate. A multifactorial 
overview of the factors eschewed concerning aluminium phosphide poisoning exposure 
was elucidated. It was supposed that collective articles detailing known factors of usage 
were not necessarily correlated with functionality and health. Collection of materials for the 
review started with the published literature or easily available academic research. 
3. Epidemiology 
Annually about 300 000 deaths are reported by pesticides poisoning worldwide (Eddleston 
& Phillips, 2004). The most reports of acute pesticide poisoning only based on hospital 
records admission and as a result absolutely reflect a small part of the real incidence. In 
Asian region about 25 million agricultural workers suffer from an episode of poisoning each 
year(Jeyaratnam, 1990). In “phosphine” poisonings reported from Germany, 28% were 
planned and mostly by eating, whereas the majority of the 65% accidental exposures were 
by inhalation (Lauterbach, et al, 2005). A report has also been publishedfrom the United 
Kingdom where the majority of 93 aluminum phosphide exposures were accidental and 
concerned inhalation of phosphine in agricultural locations(Bogle, 2006). 
4. Ingestion of phosphides 
Phosphide ingestion is a particular problem in rural India, the origin of most of the data on 
this topic (Rastogi, et al, 1990; Chugh, et al, 1991, 1998; Singh, 1996;  Gargi, et al, 2006). The 
aluminium salt is most commonly involved. Indeed, in a prospective study of 559 acute 
poisonings admitted over 14 months to a single hospital in Harayana-Rohtak, India, no 
fewer than 379 (68%) involved aluminium phosphide (Siwach & Gupta, 1995). Similarly, 
reports to the National Poisons Centre in Delhi indicate that aluminium phosphide is the 
pesticide most commonly ingested by children (Gupta, et al, 2003).  
Much smaller numbers or only sporadic cases of phosphide poisoning have been reported 
from the remainder of the world, including Australia (Nocera, et al, 2000), Denmark 
(Andersen, et al, 1996), France (Anger, et al, 2000), Germany (Alter, et al, 2001), Greece 
(Frangides & Pneumatikos, 2002), Iran (Pajoumand, et al, 2002), Jordan (Abder-Rahman, et 
al, 2000), Morocco (Idali, et al, 2005; Hajouji, et al, 2006; Akkaoui, et al, 2007), Nepal (Lohani, 
et al, 2000), Sri Lanka (Roberts, et al, 2006), Turkey (Bayazit, et al, 2000), the United Kingdom 
(Stewart, et al, 2003; Lawler & Thomas, 2007), Canada, the United States (Broderick & 
Birnbaum, 2002, Ragone, et al, 2002), the former USSR (Rimalis & Bochkarnikov, 1978), and 
Yugoslavia (Curcic & Dadasovic, 2001). A single death from ingestion of a falsely labeled 
rodenticide bait has been reported (Azoury & Levin, 1998). Phosphide rodenticides were 
responsible for nine out of 349 deaths in 35,580 poisoning admissions to Loghman Hakim 
hospital poison center in Tehran (Pajoumand, et al, 2002). 
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5. Occupational and environmental phosphine exposure 
Occupational exposures to phosphine are uncommon and rarely severe (Sudakin, 2005) but 
accidental inhalation is a particular risk to those in close proximity to grain that has had a 
metal phosphide mixed in with it. Recurring locations include ships holds (Gregorakos, et 
al, 2002, Hansen & Pedersen, 2001, Vohra, et al, 2006), rail wagons (Perotta, et al 1994, 
Vohra, et al, 2006), grain elevators (Abder-Rahman, et al, 2000), grain stores (Brautbar & 
Howard, 2002, Misra, et al, 1988), and even stores in homes (Abder-Rahman, et al, 2000). 
Potentially lethal concentrations of the gas may develop in the head-spaces of unventilated 
or poorly ventilated storage containers and domestic premises (Memis, et al, 2007). 
Phosphine may be released during the illicit manufacture of methamphetamine (Burgess, 
2001, Willers-Russo, 1999); deaths have resulted (Willers-Russo, 1999). In another incident, a 
packet of aluminium phosphide in a container from abroad burst open and the sweepings 
placed in water causing immediate fizzing and liberation of phosphine (Kamanyire & 
Murray, 2003). Close proximity to a source of phosphine is not required to be at risk of 
toxicity as phosphine gas can travel some distance as it is heavier than air (vapor density 
1.2:1). Many years ago 12 individuals in a house adjacent to a warehouse used to store 
aluminium phosphide developed vomiting and one died. The illnesses were attributed to 
phosphine (Glass, 1959). More recently exposures have been alleged after use of metal 
phosphides to control pests in adjacent buildings (Popp, 2002). 
6. Mechanism of action 
The exact mechanism of action of aluminum phosphide poisoning is still unknown, 
however an initial survey on different animals showed non-competitive cytochrome oxidase 
binding by phosphine, changes valences of haeme component of haemoglobin.Other than 
later articles, distinguished significant inhibition of catalase goes to hydrogen peroxide 
agglomeration (Price, et al, 1982), Extra-mitochondrial release of hydrogen peroxide and 
oxygen free radicals (Bolter & Chertuka, 1989), leading to lipid peroxidation and protein 
denaturation of cell membrane are reported in more recent studies (Chug, et al, 1969). Also, 
aluminum and phosphine (Potter, et al, 1993; Al-Azzawi, et al, 1990), inhibit cholinesterases 
activity . Al-Azzawi showed in vitro exposure to phosphine lead to reducing human serum 
cholinesterase activity; in addition he showed the amount of the inhibition is related to the 
duration and concentration of phosphine (Al-Azzawi, et al, 1990). On the other hand, other 
studies declared there is no erythrocyte cholinesterase activity reduction in humans after 
accidental phosphine inhalation (Heyndrickx, et al, 1976; Wilson, et al, 1980). 
7. Toxicokinetics 
Phosphine must be quickly and easily absorbed because of the short interval between 
ingestion and the appearance of systemic toxicity features. Noticeably, phosphides possibly 
absorbed as microscopic particles of unhydrolysed salt (Stewart, et al, 2003, Chan, et al, 
1983) and permanently, in vitro, interact with free hemoglobin and hemoglobin in intact 
erythrocytes (rat and human) to produce a hemichrome (a methemoglobin derivative 
resulting from distorted protein conformation) (Chin, et al, 1992, Potter, et al, 1991). Also 
Heinz bodies (denatured hemoglobin aggregates) are formed when phosphide 
concentration in vitro increases to 1.25 ppm (Potter, et al, 1991). Few cases of phosphide 
poisoning showed intravascular complications as hemolysis and methemoglobinaemia, 
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these reactions support the involvement of erythrocytes in the biotransformation of 
phosphine in vivo in humans (Stewart, et al, 2003). 
8. Clinical features 
Aluminium phosphate poisoning affects the most organs and a variety of signs and 
symptoms appear in patients. Early symptoms include nausea, vomiting, retrosternal and 
epigastric pain, dyspnea, anxious, agitation and smell of garlic (Popp, et al, 2002; Aggarwal, 
et al, 1999; Sood, et al, 1997). on the breath. Moreover shock and peripheral circulatory 
failure are mainly imperative early signs of toxicity. Mortalities in past studies have ranged 
from 40–77% and in one survey 55% occurred within 12 h of ingestion and 91% within 24 h 
(Singh, et al, 1991). 
8.1 Cardiac toxicity 
Cardiac toxicity comprises circulatory failure (Alter, et al, 2001) hypotension (Bayazit, et al, 
2000; Ragone, et al, 2002), congestion of the heart, separation of myocardial fibres by edema, 
fragmentation of fibres, non-specifc vacuolation of myocytes, focal necrosis, neutrophil and 
eosinophil infiltration were found in autopsy (Akkaoui, et al, 2007; Sinha, et al, 2005; Chugh, 
et al, 1991, Katira, et al, 1990). Also, significantly increasing left ventricular dimensions 
(Bajaj, et al, 1988), hypokinesia of the left ventricle and septum, akinesia, ejection fractions 
reduction (Bhasin, et al 1991), severe hypotension, raised systemic venous pressure, normal 
pulmonary artery wedge pressure, inadequate systemic vasoconstriction and ECG 
abnormalities (ST and T-wave changes) (Kalra, et al, 1991) are other signs and symptoms. 
8.2 Respiratory toxicity 
Tachypnea, dyspnea, crepitations, and rhonchi were present on examination in 192 out of 
418 cases (46%) of phosphide poisoning (Chugh, et al, 1991) and have been found by others 
(Gupta, et al, 2000). Pulmonary edema is common but it is not always clear whether it is 
cardiogenic or non-cardiogenic in etiology. It tends to develop 4–48 h after ingestion and the 
finding of a reduced arterial pressure of O2 without an increase in pulmonary artery wedge 
pressure, suggested it was non-cardiogenic (Kalra, et al, 1991). Others have confidently 
diagnosed adult respiratory distress syndrome (Singh, et al, 1991, Bajaj, et al, 1988, Gupta, et 
al, 1995, Chugh, et al 1989) and non-specifed pulmonary edema (Singh, et al, 1996, Chugh, et 
al, 1998). The edema fluid may be protein-rich and hemorrhagic (Singh, et al, 1996). 
8.3 Gastrointestinal toxicity 
Hematemesis (Gupta, et al, 2000), corrosive lesions of the esophagus and stomach (Madan, 
et al, 2006, Tiwari, et al, 2003), vomiting, epigastric pain, severe gastric erosions, duodenal 
erosions, esophageal strictures tracheo-oesophageal fistulae,dysphagia (Darbari, et al, 2007).  
Dysphagia may be apparent as soon as 3 or 4 days after ingestion of aluminium phosphide 
(Madan, et al, 2006, Darbari, et al, 2007) but is more usual about 2 weeks later. 
8.4 Hepatic toxicity 
Transient elevations of alanine aminotransferase and aspartate aminotransferase activities 
are not infrequent after ingestion of metal phosphides (Frangides & Pneumatikos, 2002; 
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Akkaoui, et al, 2007; Bayazit, et al, 2000; Memis, et al, 2007) but jaundice secondary to liver 
damage (Chugh, et al, 1998) is much less common. It was present in 12 out of 92 cases 
(Singh, et al, 1991) and was said to be common in another series of 15 patients (Singh, et al, 
1985) but confirmatory laboratory data were not provided. Jaundice was alleged to be 
present in 16 (52%) members of the crew of a grain freighter who inhaled phosphine after an 
accidental release (Wilson, et al, 1980) but, in the six tested, serum bilirubin concentrations 
were normal and transaminase activities only minimally disturbed, casting doubt on the 
clinical observation. Acute hepatic failure and encephalopathy was considered to be the 
cause of death in one man (Chittora, et al, 1994), while a 12-yearold girl died from a 
combination of acute hepatic failure and encephalopathy with renal failure (Bayazit, et al, 
2000). Portal edema, congestion of the portal tract and central veins, and vacuolization of 
hepatocytes are the most frequent findings at autopsy (Saleki, et al, 2007). 
8.5 Electrolyte and metabolic abnormalities 
Hypokalemia. metabolic acidosis, mixed metabolic acidosis and respiratory alkalosis, and 
acute renal failure are reported frequently. Also,Hypoglycemia and hypomagnesemia have 
been reported in several studies (Chugh, et al, 2000; Dueñas, et al, 1999). Hypokalemia is 
common soon after ingestion of metal phosphides and is probably secondary to vomiting, 
though catecholamine release could also contribute. It is thought to be the result of impaired 
gluconeogenesis and glycogenolysis (Frangides & Pneumatikos, 2002) possibly secondary to 
adrenal gland damage and low circulating cortisol concentrations (Chugh, et al, 2000). 
Hyperglycemia (Abder-Rahman, 1999) appears to be rare. The main controversy relates to 
the existence or otherwise of disturbances of magnesium homeostasis. In 1989, prompted by 
reports of the empirical use of magnesium sulphate to treat phosphide toxicity, this study 
(Singh, et al, 1989; Singh & Sharma, 1991) demonstrated that serum magnesium 
concentrations were increased, possibly secondary to release from damaged cardiac 
myocytes and hepatocytes, and confirmed the findings in subsequent studies (Singh, et al, 
1991; Singh, et al, 1990). Unfortunately, other studies have found the converse, that is serum 
and erythrocyte concentrations were reduced rather than increased. Chugh, et al, (1991) 
compared serial serum and erythrocyte magnesium concentrations in four groups of people. 
One comprised patients poisoned with aluminium phosphide who had resulting shock and 
cardiotoxicity while the second included those poisoned but without shock or cardiac 
features. The remaining two groups acted as controls, the first being patients in shock 
secondary to trauma or hemorrhage but without other features of cardiac toxicity and the 
second, normal volunteers. The only significant finding in admission samples was that cell 
and serum concentrations were lower in shocked, cardiotoxic patients (mean serum and 
RBC concentrations 0.9 and 3.7 mEq/L respectively compared with 1.8 and 5.2 mEq/L in 
volunteers). Since, first, hypomagnesemia was found in toxic shocked patients but not in 
those with non-toxic shock and secondly, 75% of those in the toxic/shock group had ECG 
changes, it was concluded that the evidence supported a causal relationship between 
hypomagnesemia and phosphide induced shock. Without intervention both serum and cell 
values returned to normal by about 24 h. The authors confirmed their findings in a later 
study (Chugh, et al, 1994) and thought the hypomagnesemia secondary to consumption in 
combating free radical stress (Chugh, et al, 1997). Hypomagnesemia has also been found in a 
recent single case of phosphine inhalation from aluminium phosphide (Dueñas, et al, 1999). 
The situation became even more complicated when, in 1994, a study (Siwach, et al, 1994) 
found themselves unable to agree with either. They found pre-treatment mean serum and 
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red cell magnesium concentrations to be normal. Concentrations were increased in the 
brains, lungs, hearts, livers, kidneys, and stomachs of fatalities but later studies showed this 
to be the result of magnesium administration and not phosphide toxicity (Siwach, et al, 
1995). Clearly, these studies cannot all be correct and the analytical method used to generate 
the results may be an important factor. The results of a study (Siwach, et al, 1994) carry 
particular weight because they used atomic absorption spectroscopy, a technique that is 
superior to the colorimetric method published in 1977 and used (Singh, et al, 1991) and the 
titan yellow method employed (Chugh, et al, 1991) despite it being claimed that results 
obtained using the former method correlated extremely well with those from atomic 
absorption spectroscopy (Khayam-Bashi, et al, 1977). If these studies (Siwach, et al, 1994) are 
considered the most reliable, there is no choice but to accept that neither hypomagnesemia 
nor hypermagnesemia is a feature of aluminium phosphide poisoning, though confirmation 
by another independent study would be welcome. 
8.6 Hematological toxicity 
Although phosphine causes Heinz body formulation and hemoglobin oxidation in vitro 
(Chin, et al, 1992; Potter, et al, 1991), intravascular hemolysis and methemoglobinaemia are 
unusual complications of phosphide poisoning in humans. Nine individuals with 
intravascular hemolysis after ingestion of aluminium phosphide have been identified from 
the literature. Three were glucose-6-phosphate dehydrogenase deficient (Srinivas, et al, 
2007), including one young man who had previously developed haemolysis when given 
primaquine (Sood, et al, 1997). Two others had no history to suggest this possible 
predisposing disorder (Aggarwal, et al, 1999; Lakshmi, 2002) and in the remaining four the 
issue was not addressed (Chugh, et al, 1991). Intravascular hemolysis was associated with 
renal failure and severe metabolic acidosis to which 3 days of vomiting and diarrhea may 
have partly contributed (Memis, et al, 2007). In addition to hemolysis one man was found to 
have methemoglobinaemia of 17% 32 h post-ingestion (Lakshmi, 2002) while another 
developed Heinz bodies (Srinivas, et al, 2007), a further indicator of damage to hemoglobin. 
Rats given aluminium phosphide had methemoglobin concentrations measured at 10 and 30 
min intervals. They increased simultaneously with those of malonyldialdehyde suggesting 
that methemoglobinaemia was secondary to increased oxygen free radical generation (Lall, 
et al, 2000). A study revealed that there is a significant association between blood level of 
methemoglobin and mortality in patients with aluminium phosphide intoxication 
(Mostafazadeh, et al, 2010). Disseminated intravascular coagulation was present in six out of 
418 patients poisoned with aluminium phosphide (Chugh, et al, 1991). 
8.7 Uncommon features 
Unusual complications of phosphide ingestion include atrial infarction (Jain, et al, 1992), 
pleural effusion (Bayazit, et al, 2000; Suman & Savani, 1999), ascites (Bayazit, et al, 2000), 
skeletal muscle damage (Khosla, et al, 1988), rhabdomyolysis (Abder-Rahman, 1999), a 
bleeding diathesis (Gupta, et al, 1990), adrenocortical congestion, hemorrhage and necrosis 
(Arora, et al, 1995), pancreatitis (Sarma, et al, 1996), and renal failure (Chugh, et al, 1991; 
Singh, et al, 1996; Bayazit, et al, 2000; Gupta, et al, 2000). Acute pericarditis has also been 
reported infrequently (Wander, et al, 1990; Chugh & Malhotra, 1992) though pericardial 
fluid was detected by echocardiography in a third of patients in one study (Bhasin, et al, 
1991). Subendocardial infarction complicated the recovery of a 16-year-old male (Kaushik, et 
al, 2007) and a 26-year-old woman who had recovered from aluminium phosphide ingestion 
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suffered an intracranial hemorrhage 5 days after the event. No explanation other than the 
poison was found (Dave, et al, 1994). 
9. Diagnosis 
A positive history of ingestion is the basis of diagnosis in most cases. The presence of typical 
clinical features, garlicky odour from the mouth and highly variable arrhythmias in a young 
patient with shock and no previous history of cardiac disease points towards aluminium 
phosphide poisoning. Aluminium phosphide poisoning risk is low down in the following 
instances, When taking patient's history should be special attention to these points:  
If the patient uses the expired one 
If aluminum phosphide is dissolved in water before use  
If the patient experiences immediate vomiting 
Confirmation can be done by the Silver Nitrate Test (Chugh, et al, 1989). In this test, 5 ml of 
gastric aspirate and 15 ml of water are put in a flask and the mouth of the flask is covered by 
filter paper impregnated with silver nitrate. The flask is heated at 50oC for 15 to 20 min. If 
phosphine is present the filter paper turns black. For performing the test on exhaled air, the 
silver nitrate impregnated filter paper is placed on the mouth of the patient and the patient 
is asked to breath through it for 15-20 minutes, blackening of the paper indicates the 
presence of phosphine in breath. The sensitivity of the test is 100%.  However the most 
specific and sensitive method for detecting the presence of PH3 in blood/air is gas 
chromatography (Vins Jansen A, Thrane, 1978). For spot sampling of phosphine in air, 
detector tubes and bulbs are available commercially (International Programme on Chemical 
Safety, 1998; Leesch, 1982). 
10. Laboratory investigations 
Laboratory evaluation is often performed to assess the prognosis. Leucopenia indicates 
severe toxicity. Increased aspartate aminotransferase or alanine aminotransferase and 
metabolic acidosis indicate moderate to severe ingestional poisoning. Electrolyte analysis 
shows decreased magnesium while potassium may be increased or decreased (Chugh, et al, 
1990). Measurement of plasma renin is significant as its level in blood carries a direct 
relationship with mortality and is raised in direct proportion to the dose of pesticide. The 
serum level of cortisol is usually found to be decreased in severe poisoning (Chugh, et al, 
1989). Chest X-ray may reveal hilar or perihilar congestion if ARDS develops. 
Electrocardiogram shows various manifestations of cardiac injury (ST depression or 
elevation, bundle branch block, ventricular tachycardia, ventricular fibrillation) (Jain, et al, 
1985; Katira, et al, 1990; Siwach, et al, 1998; Singh, et al, 1989). Wall motion abnormalities, 
generalised hypokinesia of the left ventricle, decreased ejection fraction and pericardial 
effusion can be seen in echocardiography (Chugh, 1995). 
11. Prognostic markers 
Development of refractory shock, acute respiratory distress syndrom, aspiration, 
pneumonitis, anaemia, metabolic acidosis, electrolyte imbalance, coma, severe hypoxia, 
gastrointestinal bleeding, and pericarditis are associated with poor prognosis. The outcome 
correlates best with the number of vomiting the patient gets after ingestion and the severity 
of hypotension the patient develops (Singh, et al, 1998) 95% of the patients die within 24 
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hours and the commonest cause of death in this group is arrhythmia. Death after 24 hours is 
due to shock, acidosis, acute respiratory distress syndrom and arrhythmia. The mortality 
rate is highly variable, ranging from 37-100% and can reach more than 60% even in 
experienced and well equipped centres. 
12. Management 
12.1 Decontamination 
Gastric lavage is probably best avoided after ingestion of phosphides as it might increase the 
rate of disintegration of the pesticide and increase toxicity (Maitai, et al, 2002). To reduce the 
absorption of phosphine, gastric lavage with potassium permanganate (1:10,000) is done. 
Permanganate is used as it oxidizes PH3 to form non-toxic phosphate. This is followed by a 
slurry of activated charcoal (approximately 100 gm) given through a nasogastric tube. In 
vitro studies suggested that vegetable oil and liquid paraffin inhibit phosphine release from 
phosphides (Goswami, et al, 1994) but these oils have not been tested in clinical practice. 
However, vomiting may make the administration of charcoal difficult. Although the 
administration of sodium bicarbonate via a gastric tube to decrease gastric hydrochloric acid 
has been proposed in the belief that hydrochloric acid assists the conversion of phosphide to 
phosphine, there is no experimental support for its use. Moreover, based on an 
understanding of the mechanisms of toxicity of metal phosphides, this strategy is unlikely to 
reduce morbidity and mortality. Removal of victims of phosphine inhalation from the 
contaminated atmosphere will have been carried out by the emergency service first on 
scene. Supplemental oxygen may be given if necessary but further measures for airway 
control are unlikely to be required. 
12.2 Supportive care 
Many patients will die from metal phosphide poisoning despite intensive care. Supportive 
measures are all that can be offered and should be implemented as required by clinical 
developments. The most important factor for success is resuscitation of shock and institution 
of supportive measures as soon as possible. Intravenous access should be established and 2-
3 litres of normal saline are administered within the first 8-12 hr guided by central venous 
pressure (CVP) and pulmonary capillary wedge pressure (PCWP). The aim is to keep the 
CVP at around 12-14 cm of water (Siwach, et al, 1997). Some workers have recommended 
rapid infusion of saline (3-6 litres) in the initial 3 hr (Kalra, et al, 1991). Low dose dopamine 
(4-6 μg/kg/min) is given to keep systolic blood pressure >90 mm Hg. The other 
vasopressures such as norepinephrine may be usefull in critical patients. The use of high 
doses of glucagon may benefit in the treatment of aluminum phosphide poisoning; the 
likely mechanism of action is the increase of cAMP in the myocardium, effectively 
bypassing the β-adrenergic second messenger system. Oxygen is given for hypoxia. Acute 
respiratory distress syndrom requires intensive care monitoring and mechanical ventilation.  
The blood glucose concentration should be measured in every case and hypoglycemia 
corrected if found. Similarly, hypokalemia should be sought and, if clinically indicated, at 
least partially corrected; cardiac features have resolved in occasional patients on correction 
of potassium concentrations (Kochar, et al, 2000). It must be remembered, however, that the 
onset of acidosis, renal failure and cell damage may produce life-threatening hyperkalemia. 
Metabolic acidosis should be managed conventionally. Bicarbonate level less than 15 mEq/L 
requires bicarbonate in a dose of 50-100 mEq intravenously every 8 hour (Singh, et al, 1989). 
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All types of ventricular arrhythmias are seen in these patients and the management is the 
same as for arrhythmias in other situations (International Programme on Chemical Safety, 
1998). 
12.3 Magnesium supplementation 
The problematic decision is whether or not supplemental magnesium should be given. If 
magnesium depletion does not occur such a course would appear illogical but single cases 
have been reported where magnesium administration appeared to terminate atrial 
fibrillation (Chugh, et al, 1989) and supra ventricular tachycardia and ventricular 
tachycardia (Chugh, et al, 1991). On the other hand, magnesium sulphate 3 g given 
intravenously over 30 min did not abolish very frequent ventricular ectopic beats and 
bigeminy though it restored a normal magnesium concentration (Dueñas, et al, 1999). Only a 
few studies have attempted to assess the value of magnesium sulphate in large groups of 
patients and their results are conflicting. In a study, 50 patients after aluminium phosphide 
ingestion were given high doses of magnesium and the result compared with the control 
group that was not treated. The result showed (42%) of those given supplemental 
magnesium survived compared with (40%) not so treated. In addition, treatment did not 
considerably improve survival at any dose (number of tablets) consumed. As you see 
magnesium supplementation was of no value in this study (Siwach, et al, 1994). Chugh et al. 
(2004) obtained opposite results in a case control study.  The authors showed survival 
remarkably improved after each dose ingested for those patients treated by magnesium 
(Chugh, et al, 2004). To illuminate the potential benefit of magnesium supplementation, 
additional studies are necessary. 
12.4 N-acetylcysteine 
Different studies in rats (Hsu, et al, 2000, 2002) and humans (Chugh, et al, 1997) showed 
glutathione concentrations reduction after treating with N-acetylcysteine in patients with 
aluminium phosphide poisoning (Bogle, et al, 2006). 
12.5 Pralidoxime 
There is experimental and clinical evidence that phosphine (Potter, et al, 1993) and 
aluminium (Marquis & Lerrick, 1982, 1983) inhibit acetylcholinesterase. A study (Mittra, et 
al, 2001) investigated the benefit of administering atropine 1 mg/kg and pralidoxime 5 
mg/kg parenterally to rats dosed with aluminium phosphide 10 mg/kg (5.55 × LD50) 5 min 
previously. Treatment increased the survival time by 2.5-fold in nine out of 15 animals and 
resulted in the survival of the six remaining animals. There were no survivors in the two 
control groups. Further studies are required to confirm the benefit of oximes. 
13. Conclusions 
Acute poisoning with metal phosphides, particularly aluminium phosphide, is a worldwide 
problem most commonly encountered in the Indian Sub-Continent. The clinical features 
have been well described though it is only recently that the mechanisms of toxicity have 
been more clearly understood. Poisoning from phosphides is mediated by phosphine which 
has been shown to rapidly perturb mitochondrial morphology, inhibit oxidative respiration, 
and cause a severe drop in mitochondrial membrane potential. This failure of cellular 
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respiration is likely to be due to a mechanism other than inhibition of cytochrome C oxidase 
as phosphine inhibits cytochrome C oxidase activity less dramatically in vivo than in vitro 
and only partially inhibits cytochrome C oxidase activity in humans. Phosphine can also 
form the highly reactive hydroxyl radical and inhibit both catalase and peroxidase leading 
to lipid peroxidation. The gas or gases given of in addition to phosphine when phosphide 
formulations come into contact with water or acid need to be identified and their toxicity 
determined. The observation that both aluminium and phosphine may inhibit 
acetylcholinesterase activity needs to be investigated further as does the report that the 
administration of atropine and pralidoxime reduces morbidity and mortality in aluminium 
phosphide poisoning. There is conflicting evidence also on the occurrence and clinical 
importance of magnesium disturbances which some have described. The benefit of 
magnesium supplementation has still to be determined. 
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